Enoxaparin Sodium Injection,usp Injection, Solution
Product Images NDC 0781-3502

38 FDA label images from Sandoz Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 38 technical images submitted to the FDA as part of the official labeling for Enoxaparin Sodium Injection, Usp (NDC 0781-3502). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sandoz Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure A (Figure A)

Figure A (Figure A)
Line drawing showing two hands holding a syringe with a needle cover. Arrows indicate pulling the needle cover straight off from the syringe.*
FDA Label Image

Figure B (Figure B)

Figure B (Figure B)
A black and white line drawing showing a hand holding a syringe and administering an injection on the upper arm of another person. An arrow points towards the injection site, emphasizing the correct placement and motion. The illustration highlights the proper technique for delivering an intramuscular or subcutaneous injection.*
FDA Label Image

Figure C (Figure C)

Figure C (Figure C)
A black-and-white line illustration showing a hand holding a syringe angled to inject into an arm. The syringe is positioned for subcutaneous or intramuscular injection with an arrow indicating the direction of insertion into the skin.*
FDA Label Image

Figure D (Figure D)

Figure D (Figure D)
Black and white line drawing showing a close-up of a hand gripping a syringe with an arrow indicating the thumb pressing or pulling on a ring or collar near the syringe's plunger.*
FDA Label Image

Figure E (Figure E)

Figure E (Figure E)
Black and white line drawing showing a gloved hand holding a sharps container disposal device above a container labeled 'BIOHAZARD' for proper disposal of a needle or sharp object. An arrow indicates the downward motion of placing the device into the container.*
FDA Label Image

Structural Formula (Chm 1)

Structural Formula (Chm 1)
Chemical structure diagram of a polymer with repeating units showing sodium carboxylate groups, hydroxyl groups, and variable side chains represented by R1 and R2 substituents, where R1 can be hydrogen or sodium sulfonate and R2 can be sodium sulfonate or acetyl groups.*
FDA Label Image

Chm 2 (Chm 2)

Chm 2 (Chm 2)
Chemical structure diagram showing a complex molecule with two connected saccharide rings. Functional groups include hydroxyl (OH) groups, a sodium carboxylate (COONa), an unspecified OR1 group, and a sodium sulfonate amide (NHSO3Na). The structure features oxygen atoms in ring formations linking the two main cyclic components.*
FDA Label Image

Figure 1 (Figure 1)

Figure 1 (Figure 1)
A forest plot showing relative risk comparisons between UHF and Enox across various patient subgroups, including sex, age, infarct location, diabetes status, prior myocardial infarction, fibrinolytic agent type, time to treatment, and PCI within 30 days. The plot includes the number of patients in each subgroup and percentages for UHF and Enox, with reduction in risk values. A vertical line at relative risk 1.0 indicates no difference, with arrows pointing toward Enoxaparin or UFH being better.*
FDA Label Image

Figure 2 (Figure 2)

Figure 2 (Figure 2)
A Kaplan-Meier hazard distribution function plot depicting time to death or myocardial re-infarction in days, comparing two treatments labeled Enoxaparin (circles, solid line) and UFH (triangles, dashed line). The graph includes a log-rank test p-value of less than 0.0001, indicating statistical analysis of survival curves. Number at risk counts for each day are tabulated below the graph. A smaller inset graph shows a similar comparison at 1 year with a log-rank test p-value of 0.0111.*
FDA Label Image

Parts (Parts)

Parts (Parts)
An illustration showing two states of a syringe labeled 'Before Use' and 'After Use.' Before use, the syringe contains liquid, with a needle cap covering the needle and the plunger rod fully extended. After use, the plunger rod is depressed, the liquid is expelled, and a protective sleeve covers the needle.*
FDA Label Image

Figure A (Ifu Fig A)

Figure A (Ifu Fig A)
An instructional illustration showing labeled components used for an injection procedure. Items include a prefilled syringe, a cotton ball or gauze, a sharps disposal container, an alcohol wipe, and a small adhesive bandage, each clearly identified with text and arrows pointing to the respective item.*
FDA Label Image

Figure B (Ifu Fig B)

Figure B (Ifu Fig B)
A black and white instructional illustration showing two hands interacting with a rectangular device, possibly a test cassette. One hand is lifting a peel-off adhesive strip, while the other hand holds the device steady, indicating a step in a test preparation or usage procedure.*
FDA Label Image

Figure C (Ifu Fig C)

Figure C (Ifu Fig C)
A black-and-white line drawing illustration of a syringe with a detailed section showing the placement of the expiration date on the syringe barrel. The diagram highlights the area where the expiration date is printed for clear visibility.*
FDA Label Image

Figure D (Ifu Fig D)

Figure D (Ifu Fig D)
Illustration of a syringe cross-section showing a clear liquid inside. The syringe components, including the plunger and barrel with internal detail, are visible with the liquid labeled as 'Clear Liquid' inside the barrel.*
FDA Label Image

Figure E (Ifu Fig E)

Figure E (Ifu Fig E)
Chemical structure diagram showing a molecule composed of multiple carbon and oxygen atoms arranged in rings and chains. The structure includes hydroxyl (OH) groups and ether oxygen atoms, representing a complex organic compound.*
FDA Label Image

Figure F (Ifu Fig F)

Figure F (Ifu Fig F)
An illustration of a hand holding a cotton pad or swab, pressing it onto a surface or object shown partially at the bottom of the image. The hand is shaded and outlined in black with fingernails visible, while the cotton pad is a small square shape being touched by the fingertips.*
FDA Label Image

Figure G (Ifu Fig G)

Figure G (Ifu Fig G)
An instructional illustration showing two hands preparing a syringe. The left hand is holding the syringe cap, and the right hand is holding the syringe with the needle exposed. Arrows indicate the cap being removed from or placed onto the syringe needle.*
FDA Label Image

Figure H (Ifu Fig H)

Figure H (Ifu Fig H)
An instructional diagram showing a hand adjusting the dose on a marked syringe. The plunger is being pushed down with the thumb, indicated by a downward arrow, to set the desired dosage level shown on the syringe barrel.*
FDA Label Image

Figure I (Ifu Fig I)

Figure I (Ifu Fig I)
A grayscale line drawing illustration showing a hand gripping a device with a short nozzle or tip. The index finger is positioned behind the nozzle, and the thumb rests on the side of the device. The image focuses on finger placement relative to the device tip.*
FDA Label Image

Figure J (Ifu Fig J)

Figure J (Ifu Fig J)
A black-and-white instructional illustration showing a hand holding a syringe and injecting at a right angle (90 degrees) into the side of a bent knee. An arrow and angle mark emphasize the 90-degree angle for the injection technique.*
FDA Label Image

Figure K (Ifu Fig K)

Figure K (Ifu Fig K)
A black and white instructional illustration depicting a hand holding a syringe with the needle inserted into the skin, likely for an injection. An arrow points to the left, indicating the direction related to the action shown. The illustration focuses on proper needle positioning and hand placement for administration.*
FDA Label Image

Figure L (Ifu Fig L)

Figure L (Ifu Fig L)
An illustration showing a hand holding a syringe to inject into the forearm of the opposite arm. The image depicts the injection angle and placement, with an arrow indicating direction, demonstrating a subcutaneous or intramuscular injection technique.*
FDA Label Image

Figure M (Ifu Fig M)

Figure M (Ifu Fig M)
Instructional illustration showing a hand holding a syringe with a protective clear sleeve. The illustration indicates pushing the plunger to the right until a click is felt, as shown by an arrow and sound lines near the plunger.*
FDA Label Image

Figure N (Ifu Fig N)

Figure N (Ifu Fig N)
A labeled instructional illustration showing a hand holding a syringe with a needle cap near the opening of a sharps disposal container. The container is depicted with a lid that has a hole for safely disposing of used syringes and needles.*
FDA Label Image

Ndc 078103460-63 (30mg Carton)

Ndc 078103460-63 (30mg Carton)
Packaging label for Enoxaparin Sodium Injection, USP 30 mg/0.3 mL. The box indicates ten 0.3 mL single-dose syringes with automatic safety devices for subcutaneous use. The label includes storage instructions, warnings to keep out of reach of children, and distributor information showing Sandoz Inc., Princeton, NJ. The packaging also has a barcode and a revision date of 05/2024.*
FDA Label Image

Ndc 0781-3460-01 (30mg Blister Label)

Ndc 0781-3460-01 (30mg Blister Label)
The image shows a repeated product label for Enoxaparin Sodium Injection, USP 30 mg/0.3 mL. The label indicates it is for subcutaneous use and comes in a single-dose 0.3 mL syringe with an automatic safety device. The label includes storage instructions, dosage warnings, NDC 0781-3460-01, and distribution information by Sandoz Inc., Princeton, NJ. The revision date is May 2024.*
FDA Label Image

Ndc 0781-3482-63 (40mg Carton Label)

Ndc 0781-3482-63 (40mg Carton Label)
Packaging label for Enoxaparin Sodium Injection, USP 40 mg/0.4 mL. The label indicates ten 0.4 mL single-dose syringes with automatic safety devices for subcutaneous use. It includes storage instructions to keep at 25°C with permitted excursions and a warning to keep out of reach of children. Distributed by Sandoz Inc., Princeton, NJ, it notes product origin as China and has barcode and revision date 05/2024.*
FDA Label Image

Ndc 0781-3482-01 (40mg Blister Label)

Ndc 0781-3482-01 (40mg Blister Label)
Labels for Enoxaparin Sodium Injection, USP 40 mg/0.4 mL, a subcutaneous injection supplied in single-dose syringes with automatic safety devices. Labels indicate Rx only status, storage instructions, dosage form, and manufacturer/distributor Sandoz Inc., Princeton, NJ. Each label includes barcodes, warnings, and a peel-off section.*
FDA Label Image

Ndc 0781-3488-63 (60mg Carton Label)

Ndc 0781-3488-63 (60mg Carton Label)
Packaging label for Enoxaparin Sodium Injection, USP with a strength of 60 mg/0.6 mL. The label states the product comes in ten 0.6 mL single-dose syringes with automatic safety devices for subcutaneous use. Manufacturer or distributor information includes Sandoz Inc., Princeton, NJ. Storage instructions and warnings are also present on the label.*
FDA Label Image

Ndc 0781-3488-01 (60mg Blister Label)

Ndc 0781-3488-01 (60mg Blister Label)
Packaging label for Enoxaparin Sodium Injection, USP 60 mg/0.6 mL for subcutaneous use. Label indicates a single-dose syringe with an automatic safety device. The product is distributed by Sandoz Inc., Princeton, NJ 08540. The label includes storage instructions, dosing information, warning to keep out of reach of children, and barcodes, repeated multiple times in a grid layout.*
FDA Label Image

Ndc 0781-3502-63 (80mg Carton Label)

Ndc 0781-3502-63 (80mg Carton Label)
Packaging label for Enoxaparin Sodium Injection, USP with a strength of 80 mg/0.8 mL. The label indicates a package containing ten 0.8 mL single-dose syringes with automatic safety devices for subcutaneous use. The product is Rx Only and distributed by Sandoz. Additional text includes dosage and administration warnings, storage instructions, and a barcode.*
FDA Label Image

Ndc 0781-3502-01 (80mg Blister Label)

Ndc 0781-3502-01 (80mg Blister Label)
A sheet of multiple identical drug labels for Enoxaparin Sodium Injection, USP, each labeled with strength 80 mg/0.8 mL. The labels indicate the product is for subcutaneous use, supplied as a 0.8 mL single-dose syringe with automatic safety device. The label shows the distributor as Sandoz Inc., Princeton, NJ, with storage instructions and a barcode. Each label includes cautionary and dosage information along with a visible NDC number 0781-3502-01.*
FDA Label Image

Ndc 0781-3505-63 (100mg Carton Label)

Ndc 0781-3505-63 (100mg Carton Label)
Packaging label for Enoxaparin Sodium Injection, USP 100 mg/1 mL. The label indicates ten 1 mL single-dose syringes with an automatic safety device for subcutaneous use. Manufactured by Sandoz, the label includes dosage and storage instructions, a barcode, and states the product is distributed by Sandoz Inc., Princeton, NJ.*
FDA Label Image

Ndc 0781-3505-01 (100mg Blister Label)

Ndc 0781-3505-01 (100mg Blister Label)
A sheet of multiple identical packaging labels for Enoxaparin Sodium Injection, USP, 100 mg/1 mL. Each label states it is for subcutaneous use with a 1 mL single-dose syringe featuring an automatic safety device. Distributed by Sandoz Inc., Princeton, NJ. Labels include storage instructions, dosage and administration notes, warnings, and barcodes. Red 'Peel Here' tabs are visible on the left side.*
FDA Label Image

Ndc 0781-351063 (120mg Carton Label)

Ndc 0781-351063 (120mg Carton Label)
Packaging label for Enoxaparin Sodium Injection, USP, 120 mg/0.8 mL. The label indicates ten 0.8 mL single-dose syringes with automatic safety devices for subcutaneous use. The product is distributed by Sandoz Inc., Princeton, NJ. The label includes dosage administration and storage instructions, warnings, and identifies the product's origin as China.*
FDA Label Image

Ndc 0781-3510-1 (120mg Blister Label)

Ndc 0781-3510-1 (120mg Blister Label)
Label images repeated of Enoxaparin Sodium Injection, USP, 120 mg/0.8 mL for subcutaneous use. The label notes a single-dose syringe with an automatic safety device, storage instructions, dosing and administration references, and warnings. Distributed by Sandoz Inc., Princeton, NJ, with a revision date of 05/2024 and barcodes present.*
FDA Label Image

Ndc 0781-3513-63 (150mg Carton Label)

Ndc 0781-3513-63 (150mg Carton Label)
Packaging label for Enoxaparin Sodium Injection, USP, 150 mg/1 mL. The label indicates the product consists of ten 1 mL single-dose syringes with an automatic safety device intended for subcutaneous use. The product is distributed by Sandoz Inc., Princeton, NJ, and includes storage instructions and a warning to keep out of reach of children. Revision date is 05/2024.*
FDA Label Image

Ndc 0781-3513-01 (150mg Blister Label)

Ndc 0781-3513-01 (150mg Blister Label)
Label for Enoxaparin Sodium Injection, USP 150 mg/1 mL, for subcutaneous use. The label states it is a 1 mL single-dose syringe with an automatic safety device. Distributed by Sandoz Inc., Princeton, NJ. Storage instructions and warnings about keeping out of reach of children and temperature conditions are included. The label also displays NDC 0781-3513-01 and barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.